{"id":55736,"date":"2025-12-02T17:21:05","date_gmt":"2025-12-02T11:51:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=55736"},"modified":"2025-12-02T17:21:34","modified_gmt":"2025-12-02T11:51:34","slug":"invicta-diagnostic-ipo-gmp-day-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/","title":{"rendered":"Invicta Diagnostic IPO GMP: Day 2 IPO Live Updates"},"content":{"rendered":"<p>The <strong>Invicta Diagnostic IPO GMP <\/strong>is \u20b90 as of 1st December 2025. It is a bookbuilding IPO of \u20b928.12 crores. This is an entirely fresh issue of 33,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 8th December 2025. The face value of Invicta Diagnostic IPO shares is \u20b910 per share, and the IPO price band is \u20b980 to \u20b985 per share. Retail investors can bid for a minimum of 2 lots of 3,200 shares worth \u20b92,72,000.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Invicta_Diagnostic_IPO_GMP_Grey_Market_Premium\" title=\"Invicta Diagnostic IPO GMP Grey Market Premium\">Invicta Diagnostic IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Invicta_Diagnostic_IPO_Details\" title=\"Invicta Diagnostic IPO Details\">Invicta Diagnostic IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Invicta_Diagnostic_IPO_Objectives\" title=\"Invicta Diagnostic IPO Objectives\">Invicta Diagnostic IPO Objectives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Invicta_Diagnostic_IPO_Registrar\" title=\"Invicta Diagnostic IPO Registrar\">Invicta Diagnostic IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Invicta_Diagnostic_IPO_Review\" title=\"Invicta Diagnostic IPO Review\">Invicta Diagnostic IPO Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Invicta_Diagnostic_IPO_Limited_Technicals\" title=\"Invicta Diagnostic IPO Limited Technicals\">Invicta Diagnostic IPO Limited Technicals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#FAQs_on_Invicta_Diagnostic_IPO\" title=\"FAQs on Invicta Diagnostic IPO\">FAQs on Invicta Diagnostic IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#What_is_the_Invicta_Diagnostic_IPO_GMP\" title=\"What is the Invicta Diagnostic IPO GMP?\">What is the Invicta Diagnostic IPO GMP?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#What_is_the_issue_price_of_Invicta_Diagnostic_IPO\" title=\"What is the issue price of Invicta Diagnostic IPO?\">What is the issue price of Invicta Diagnostic IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Who_is_the_registrar_of_Invicta_Diagnostic_IPO\" title=\"Who is the registrar of Invicta Diagnostic IPO?\">Who is the registrar of Invicta Diagnostic IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp-day-2\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Invicta Diagnostic IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of 2nd December 2025, the <strong>Invicta Diagnostic IPO GMP <\/strong>stands at \u20b90 per share. Thus, the estimated listing price would be \u20b985. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the <strong>Invicta Diagnostic IPO GMP<\/strong> updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>2-12-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>1-12-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>30-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>29-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>28-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>27-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>26-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Details\"><\/span><strong>Invicta Diagnostic IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>1st December 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>3rd December 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>4th December 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>5th December 2025<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b980 to \u20b985 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,600 Shares<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>33,08,800 shares(aggregating up to \u20b928.12 Cr)<\/td><\/tr><tr><td><strong>Issue Type&nbsp;<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>NSE and SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>8th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Invicta Diagnostic IPO<\/strong>: Invicta Diagnostic IPO Limited has declared an issue price band of \u20b980.00 to \u20b985.00 per share. With this IPO, the company allows retail investors to bid for at least two lots of 3,200 shares, each worth \u20b92,72,000. The face value of Invicta Diagnostic IPO Limited shares is \u20b910 per share. The shares of Invicta Diagnostic IPO Limited will be listed on BSE and SME on its tentative listing day, 8th December 2025. Scroll down to check GMP updates and <strong>Invicta Diagnostic IPO <\/strong>reviews.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Objectives\"><\/span><strong>Invicta Diagnostic IPO Objectives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Invicta Diagnostic IPO<\/strong> is to raise \u20b928.12 crores. On the other hand, Invicta Diagnostic has decided to utilise these funds in different ways. Explore some of the secondary objectives for the <strong>Invicta Diagnostic IPO<\/strong>.<\/p><ul class=\"wp-block-list\"><li>Funding capital expenditure for the purchase of medical equipment towards the establishment of five new diagnostic centres in Maharashtra<\/li>\n\n<li>General Corporate purposes<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Registrar\"><\/span><strong>Invicta Diagnostic IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>According to recent updates, Bigshare Services Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Invicta Diagnostic IPO GMP, allotment, or refund, please contact the investor relations team at Bigshare Services Private Limited, <a href=\"mailto:ipo@bigshareonline.com\">ipo@bigshareonline.com<\/a> or +91-22-6263 8200.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Review\"><\/span><strong>Invicta Diagnostic IPO Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-1024x536.jpg\" alt=\"Apply For Invicta Diagnostic IPO GMP\" class=\"wp-image-55739\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The <strong>Invicta Diagnostic IPO <\/strong>has gained neutral ratings from industry experts, brokers, and institutional investors. Invicta Diagnostic&nbsp; Limited&#8217;s revenue soared by 90% from \u20b915.90 crores in March 2024&nbsp; to \u20b930.18 crores in March 2025. Moreover, the company&#8217;s PAT increased by 30% from \u20b93.81 crores in March 2024 to \u20b94.93 crores in March 2025. Investors can analyse other relevant factors and make a decision accordingly.<\/p><p>Investors can analyse other relevant factors and make a decision accordingly.<\/p><p>Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we\u2019re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for <strong>Invicta Diagnostic IPO <\/strong>or not.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Limited_Technicals\"><\/span><strong>Invicta Diagnostic IPO Limited Technicals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)&nbsp;<\/strong><\/a><\/td><td>15.97<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>5.32<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>36.25%<\/td><\/tr><tr><td><strong>ROCE<\/strong><\/td><td>42.00%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>44.28%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>30.57%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>5.26<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9106.86 Cr.<\/td><\/tr><\/tbody><\/table><\/figure><p>The P\/E ratio of Invicta Diagnostic&nbsp; Limited&#8217;s shares is 15.97, and its Earnings Per Share (EPS) is 5.32. Thus, the <strong>Invicta Diagnostic&nbsp; Limited IPO<\/strong> can deliver gains on its tentative listing day, 8th December 2025<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Invicta Diagnostic IPO Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>15.97<\/td><td>13.08<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>5.32<\/td><td>13.08<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Invicta_Diagnostic_IPO\"><\/span><strong>FAQs on Invicta Diagnostic IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Invicta_Diagnostic_IPO_GMP\"><\/span><strong>What is the Invicta Diagnostic IPO GMP?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Currently, on 2nd December 2025, the <strong>Invicta Diagnostic IPO GMP<\/strong> (Grey Market Premium) stands at \u20b90. This indicates that the estimated listing price could be \u20b985 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_Invicta_Diagnostic_IPO\"><\/span><strong>What is the issue price of Invicta Diagnostic IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The <strong>Invicta Diagnostic IPO<\/strong> issue price band is set at \u20b980 to \u20b985 per share. Retail investors can apply for a minimum of 2 lots consisting of 3,200 shares worth \u20b92,72,000. Moreover, HNIs are required to bid for a minimum of 3 lots (4,800 shares) worth \u20b94,08,000.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_Invicta_Diagnostic_IPO\"><\/span><strong>Who is the registrar of Invicta Diagnostic IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Bigshare Services Pvt Limited is the registrar for the <strong>Invicta Diagnostic IPO,<\/strong> awaiting to manage the allotment process and initiation of refunds. For any queries regarding the Invicta Diagnostic allotment and refund, you can contact Bigshare Services Pvt. Ltd. at <a href=\"mailto:ipo@bigshareonline.com\">ipo@bigshareonline.com<\/a> or +91-22-6263 8200.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Invicta Diagnostic IPO, download the Invicta Diagnostic IPO RHP and Invicta Diagnostic IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/max-healthcare-q1-results-fy26\">Max Healthcare Q1 Results FY26: Q1 PAT Rises 30.35% to \u20b9307.97 Crore; Revenue Up 31.41% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/minda-corporation-q1-results-fy26\">Minda Corporation Q1 Results FY26: Q1 PAT Rises 1.73% to \u20b965.31 Crore; Revenue Up 16.23% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bharat-dynamics-q1-results-fy26\">Bharat Dynamics Q1 Results FY26: Q1 PAT Rises 154.30% to \u20b918.35 Crore; Revenue Up 29.69% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/elitecon-international-q1-results-fy26\">Elitecon International Q1 Results FY26: Q1 PAT Rises 349.99% to \u20b920.41 Crore; Revenue Up 301.98% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/elgi-equipments-q1-results-fy26\">Elgi Equipments Q1 Results FY26: Q1 PAT Rises 17.58% to \u20b985.60 Crore; Revenue Up 8.19% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/aavas-financier-q1-results-fy26\">Aavas Financier Q1 Results FY26: Q1 PAT Rises 10.41% to \u20b9139.23 Crore; Revenue Up 15.70% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/regaal-resources-ipo-gmp-2\">Invicta Diagnostic IPO GMP: Day 2 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Invicta Diagnostic IPO GMP is \u20b90 as of 1st December 2025. It is a bookbuilding IPO of \u20b928.12 crores. This is an entirely fresh issue of 33,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 8th December 2025. The face value of Invicta Diagnostic IPO shares is<\/p>\n","protected":false},"author":23,"featured_media":55737,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[3531],"class_list":["post-55736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-invicta-diagnostic-ipo-gmp"],"metadata":{"_edit_lock":["1764676294:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:91:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1.jpg\";a:2:{s:2:\"id\";i:55739;s:11:\"source_type\";s:13:\"media-library\";}s:100:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-1024x536.jpg\";a:2:{s:2:\"id\";i:55739;s:11:\"source_type\";s:13:\"media-library\";}s:123:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1.jpg\";a:2:{s:2:\"id\";i:55739;s:11:\"source_type\";s:13:\"media-library\";}s:132:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171532\/Invicta-Diagnostic-IPO-Apply-or-Avoid-1-1024x536.jpg\";a:2:{s:2:\"id\";i:55739;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["76"],"rank_math_title":["Invicta Diagnostic IPO GMP Day 2 | Check IPO Details"],"rank_math_description":["Invicta Diagnostic IPO GMP status. Discover the IPO Price, Date, Subscription Status, Grey Market Premium (GMP), Allotment, Listing Date, and Review. Read more!\r\n"],"rank_math_focus_keyword":["Invicta Diagnostic IPO GMP"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["55737"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4918"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/invicta-diagnostic-ipo-gmp-day-2"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02171217\/Invicta-Diagnostic-IPO-GMP-Day-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=55736"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55736\/revisions"}],"predecessor-version":[{"id":55740,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55736\/revisions\/55740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/55737"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=55736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=55736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=55736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}